SARA KIM: Open Payments
NPI 1841063179 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,103 in 131 payments from 42 companies in 2025. Trend: 2023 $84 · 2024 $2,461 · 2025 $3,103
Food & beverage: $3,004Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $307 |
| Novartis Pharmaceuticals Corporation | 16 | $293 |
| Merck Sharp & Dohme LLC | 12 | $278 |
| Incyte Corporation | 9 | $210 |
| AstraZeneca Pharmaceuticals LP | 7 | $172 |
| GlaxoSmithKline, LLC. | 4 | $138 |
| ABBVIE INC. | 5 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $98 |
| BeOne Medicines USA, Inc. | 4 | $97 |
| Eisai Inc. | 3 | $85 |
Products named: KEYTRUDA, JEMPERLI, KISQALI, DARZALEX, Epkinly, BRUKINSA, IMFINZI, Lenvima.
Industry payments across MD — which companies pay providers there.
